Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor activity of Geron's telomerase inhibitor reported in presentation at ASH meeting

Dec. 11, 2002

New proline-based MMP inhibitors in early development at Aventis

Dec. 11, 2002

New proapoptotic compounds identified at Cell Pathways

Dec. 11, 2002

Inhibitors of CDK2, CDK5 and/or GSK-3 covered by Pfizer patent

Dec. 11, 2002

Patent for p53/taxane combination therapy awarded to Aventis, licensed to Introgen

Dec. 11, 2002

Epimmune files IND for cancer vaccine

Dec. 10, 2002

Millennium to submit Velcade NDA and MAA filings by early 2003

Dec. 10, 2002

huN901-DM1 enters phase II portion of U.S. SCLC study

Dec. 10, 2002

Corixa and Kirin collaborate on WT1 cancer vaccine development

Dec. 9, 2002

Apoptosis-inducing hydrazones as novel antitumor agents

Dec. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...